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Abstract
Background:  Whirling disease, caused by the pathogen Myxobolus cerebralis, afflicts several
salmonid species. Rainbow trout are particularly susceptible and may suffer high mortality rates.
The disease is persistent and spreading in hatcheries and natural waters of several countries,
including the U.S.A., and the economic losses attributed to whirling disease are substantial. In this
study, genome-wide expression profiling using cDNA microarrays was conducted for resistant
Hofer and susceptible Trout Lodge rainbow trout strains following pathogen exposure with the
primary objective of identifying specific genes implicated in whirling disease resistance.
Results: Several genes were significantly up-regulated in skin following pathogen exposure for both
the resistant and susceptible rainbow trout strains. For both strains, response to infection appears
to be linked with the interferon system. Expression profiles for three genes identified with
microarrays were confirmed with qRT-PCR. Ubiquitin-like protein 1 was up-regulated over 100 fold
and interferon regulating factor 1 was up-regulated over 15 fold following pathogen exposure for
both strains. Expression of metallothionein B, which has known roles in inflammation and immune
response, was up-regulated over 5 fold in the resistant Hofer strain but was unchanged in the
susceptible Trout Lodge strain following pathogen exposure.
Conclusion: The present study has provided an initial view into the genetic basis underlying
immune response and resistance of rainbow trout to the whirling disease parasite. The identified
genes have allowed us to gain insight into the molecular mechanisms implicated in salmonid immune
response and resistance to whirling disease infection.
Background
Whirling disease was first described among farmed rain-
bow trout (Oncorhynchus mykiss), a native North American
salmonid species, introduced to Germany as a food fish in
the late 1800s [1]. Whirling disease is associated with sys-
temic infections by the myxozoan Myxobolus cerebralis, a
parasite with presumed origins among salmonid fish in
Eurasia [2,3]. Rainbow trout are highly susceptible to
whirling disease and the introduction of the parasite to
the U.S.A. in the 1950s had immediate economic impacts
on salmonid hatcheries in both eastern and western states
[2]. The parasite has a broad worldwide distribution and
has been identified in 25 states in the U.S.A. where salmo-
nid fish are present [4]. Salmonid hatcheries throughout
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the U.S.A have suffered drastic economic losses due to
whirling disease outbreaks. The disease has more recently
been recognized as the principal cause of major popula-
tion declines among wild rainbow trout populations in
the intermountain region of the U.S.A with serious nega-
tive impacts on sportfishing and allied industries [5-7].
Additionally, concerns continue over the potential nega-
tive ecologic impacts of whirling disease on wild salmo-
nid populations, particularly threatened or endangered
salmonids such as bull trout (Salvelinus confluentus), cut-
throat trout (Oncorhynchus clarki), and steelhead (Onco-
rhynchus mykiss) [8,9].
Myxobolus cerebralis has a complex life cycle that includes
two alternate hosts, a salmonid fish and an oligochaete
worm, Tubifex tubifex [10,11]. Infection in the salmonid
host begins when microscopic waterborne actinospore
stages of M. cerebralis are released from the worm and con-
tact the skin of the fish host. Actinospores, also referred to
as triactinomyxons for M. cerebralis, attach preferentially
to fins and the buccal cavity where they release one or
more of three coiled polar filaments which penetrate and
then anchor them to the epidermis[12]. Within minutes
the sporoplasm, which contains 64 internal cells, migrates
from the triactinomxyon to deeper layers of the epider-
mis, an action that may be facilitated by parasite proteases
[13-15]. Aggregates and single cells from the sporoplasm
then begin mitotic replication within two h of initial
infection, alternating between inter and intracellular loca-
tions, a process that may also depend upon parasite coded
protease activity [15,16]. Over the next 10 h at water tem-
peratures of 15°C, parasites within host epithelial cells
further divide by the process of endogeny or cell within
cell replication prior to release and then penetration of
new host cells. Between 12 and 20 h post infection, the
number of parasite cells present in the epidermis steadily
declines until new stages are observed in the subcutis at 48
h. Degenerative stages observed in the epidermis between
12 and 20 h are suspected to be a result of the action of the
host immune response, although the cellular and or
humoral factors involved are not currently known. After a
brief residence in the subcutis, parasite stages are pre-
sumed to migrate to proximal nervous tissues, initially in
peripheral and then more central locations [16]. Migra-
tion and potential replication of parasite stages in nervous
tissue ensues over the next 16 d with the first parasites
exiting to invade cartilage observed at 20 d post infection
[16]. Feeding on cartilage may induce a host inflamma-
tory response that constricts the spinal cord, brain stem,
and caudal nerves resulting in the erratic swimming
behavior (whirling) and black tail observed among fish
with acute whirling disease [17]. An additional impact of
cartilage destruction are permanent deformities to the
skeletal system that may increase vulnerability to preda-
tion and impair ability to forage for food [1]. The final
developmental stages of the parasite in the fish are envi-
ronmentally resistant spore stages (myxospores) which
remained trapped in cartilage or bone [18]. Death of
infected fish or ingestion by fish or avian predators
releases myxospores from the fish tissues and they may be
ingested by the second host, the benthic dwelling oligo-
chaete T. tubifex [19]. A second developmental cycle then
occurs under the mucosal lining of the intestine that
results in the release of thousands of the actinospore (tri-
actinomyxon) stages potentially over the entire lifetime of
the individual oligochaete [20].
Susceptibility to whirling disease in U.S. rainbow trout
strains is pervasive with only two of the tested native
strains displaying any degree of resistance, which may be
inconsistent and relatively moderate [21,22]. Hatchery
rainbow trout in Germany (Hofer strain), however, have
acquired a degree of resistance to whirling disease that is
consistently much higher than any domestic rainbow
strains and comparable to that of brown trout (Salmon
trutta), which are native to Europe and typically asympto-
matic following infection [23]. Laboratory tests compar-
ing rainbow trout strains under the same environmental
conditions and pathogen exposure indicate that the Hofer
strain's ability to combat M. cerebralis infection has a
genetic basis. Recently, controlled crosses of the Hofer
strain and a susceptible strain (Colorado River rainbow
trout [CRR]) demonstrated that resistance to whirling dis-
ease was inherited by progeny [24] and heritability esti-
mates are currently underway.
The discovery of the resistant Hofer strain allowed us to
conduct an intraspecific comparison of susceptible and
resistant rainbow trout in order to gain insight into the
genetic basis underlying whirling disease susceptibility for
this species. Gene expression profiling, through the use of
microarrays, is an extremely high-throughput method to
discover specific genes and pathways involved in a disease
phenotype without the bias of a candidate gene approach.
In this study, microarray analysis was used to examine
expression changes in a resistant and susceptible strain of
rainbow trout following exposure to M. cerebralis, the
pathogen causing whirling disease. We have found several
genes significantly up-regulated in both the resistant and
susceptible strain that appear to be involved in host
response to infection. We have also found a gene which is
significantly up-regulated in the resistant but remains
unchanged in the susceptible rainbow trout strain follow-
ing pathogen exposure that is a likely candidate gene for
involvement in conferring whirling disease resistance.
Results and Discussion
Quantitative PCR conducted on caudal fin tissues at two
hours post exposure to M. cerebralis demonstrated eachBMC Genomics 2008, 9:37 http://www.biomedcentral.com/1471-2164/9/37
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fish strain had similar initial pathogen loads, although
there was substantial variation between individual fish
within each strain. The mean parasite copy numbers per
host cell were 1.20 × 106 (SD 1.53 × 106) for the Hofer and
1.04 × 106 (SD 0.91 × 106) for the Trout Lodge. These
mean values and standard deviations are similar to those
obtained in additional studies of susceptible rainbow
trout when examined at early time points post TAM expo-
sure (unpublished data).
In order to study genes involved in whirling disease
response, resistant and susceptible rainbow trout strains
were exposed to M. cerebralis and RNA from skin tissue
was converted to cDNA and hybridized onto microarrays.
Relative gene expression for exposed and unexposed con-
trols for each strain was compared and the list of differen-
tially expressed genes for both strains is found in Table 1.
A combined total of 17 genes or features (14 annotated
genes, 3 unknown features) were differentially expressed
in one or both strains following pathogen exposure and
are involved with rainbow trout infection response to
whirling disease exposure. Several of these genes were
found in different locations on the array as unique
expressed sequence tag (EST) clones and their repeated
presence on the significance gene lists provides additional
support for their involvement in the whirling disease phe-
notype. The small number of genes found potentially
indicates that only a few genes contribute to the pheno-
typic differences found between resistant Hofer and sus-
ceptible Trout Lodge, at least in terms of differential gene
expression, during early disease progression in the skin. In
the microarray statistical analysis, when the delta value
Table 1: EST clones significantly up-regulated in resistant and susceptible rainbow trout strains 24 hours after Myxobolus cerebralis 
exposure using a Wilcoxon test.
Strain Gene Accession Fold Change
H Ubiquitin-like protein 1* CB499972 8.98
H Ubiquitin-like protein 1* CA064176 3.80
H Interferon regulating factor 1* CA063565 7.24
H Interferon regulating factor 1* CA058315 3.63
H PPAR-α-interacting complex protein 285* CA056844 7.88
H Similar to interferon-inducible protein Gig2* CA054168 5.82
H Metallothionein B* CB507722 4.36
H Metallothionein B * CB508872 3.08
H Metallothionein B* CA046225 2.72
H Metallothionein B CK990592 2.00
H Metallothionein B* CB510653 3.55
H Interferon regulatory factor 7* CB500977 4.36
H Cyclin-dependent kinase 4 inhibitor B CA044251 3.12
H Cyclin-dependent kinase 4 inhibitor B CB499959 2.66
H Beta-2 microglobulin precursor CN442516 2.51
H Beta-2 microglobulin precursor CB498391 2.23
H Beta-2 microglobulin precursor CB496576 2.12
H Beta-2 microglobulin precursor CB505897 2.04
H Beta-2 microglobulin precursor CA043324 2.02
H Proteasome subunit beta type 8 precursor CB496486 2.39
H Interferon-induced 35 kDa protein homolog CB493302 2.38
H Haptoglobin precursor CA038906 2.20
H VHSV-induced protein CB498971 2.07
H Neighbor of COX-4 CB517140 2.01
H Unknown CA050082 2.71
H Unknown CA062379 2.70
H Unknown CB515535 2.41
TL Ubiquitin-like protein 1* CB499972 7.56
TL Ubiquitin-like protein 1 CA064176 3.47
TL Interferon regulating factor 1* CA063565 4.81
TL Interferon regulating factor 1 CA058315 2.80
TL Interferon regulating factor 1 CA063863 2.55
TL PPAR-alpha-interacting complex protein 285* CA056844 3.31
TL Similar to interferon-inducible protein Gig2 CA054168 3.20
TL Similar to CC chemokine SCYA113 CB503743 2.26
TL Unknown CA062379 2.30
H = Hofer (resistant strain); TL = Trout Lodge (susceptible strain); * = In addition to being significant using the Wilcoxon rank sum, these genes are 
also significant using the modified t-test employed in SAM. Q-values < 1% were considered significant for both tests.BMC Genomics 2008, 9:37 http://www.biomedcentral.com/1471-2164/9/37
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was adjusted even slightly lower, the FDR estimate
increases from 0% to ~78%. Since increasing the FDR cut-
off to such a high percentage would dramatically reduce
power, we chose to leave the gene list small with an esti-
mated FDR of 0%. This type of dramatic increase in FDR
estimation is additional support that there are not many
genes differentially expressed in response to whirling dis-
ease infection for our chosen tissue and time points.
Different salmonid microarray platforms, such as those
available from Oregon State University and Michigan
State University, or different tissues and time points may
produce additional candidate genes. A recent time course
study used a candidate gene approach to identify four
genes (TGF-β, IL-1β1, IL-1β2, and COX-2) that were sig-
nificantly up-regulated by both Hofer and Trout Lodge in
response to whirling disease infection [25]. These genes
and their downstream effectors were not identified in the
current microarray study, likely due to many differences in
experimental design between the two studies (e.g., patho-
gen exposure levels, tissue types, water temperatures, age
of fish at exposure, etc.). While downstream effectors of
these genes were present on the microarray, only one of
the four genes (COX-2) was actually present on the micro-
array. It is our hope that future genome sequencing will
enable the construction of more comprehensive microar-
ray platforms for economically important aquaculture
species, such as Atlantic salmon and rainbow trout.
All significant genes identified by the current microarray
study were up-regulated following pathogen exposure for
one or both strains. Therefore, it appears that both strains
are undergoing transcriptional activation to defend
against whirling disease infection and thus, are exclusively
employing positive regulation for the genes examined in
skin during early disease progression.
The normal caveats that apply for microarray studies
(gene discovery is limited by transcripts on arrays, differ-
ences at transcriptional level may not cause phenotypic
differences, results are dependent upon tissue type and
time point chosen, etc.) apply for this study. Additionally,
the comparison of two rainbow trout strains (i.e., resistant
versus susceptible) added another layer of complexity to
the analysis. We chose to not directly compare the two
strains because there could be expression differences
between them, due to divergence following strain isola-
tion, that are unrelated to the whirling disease phenotype.
With that in mind, the two strains were first compared
entirely separately from each other to discover expression
differences in response to pathogen exposure for each
strain. Only the genes responding to infection, and there-
fore implicated in the whirling disease phenotype, were
compared between the two strains for differential gene
expression (Figure 1). A limitation of this approach to our
study is that constitutively expressed transcripts which are
differentially expressed between the two strains that con-
tribute to the whirling disease phenotype cannot be iden-
tified.
Microarray analysis of genes differentially expressed in the 
resistant Hofer strain in response to pathogen exposure
A total of 16 genes or features (13 annotated genes, 3
unknown features) were up-regulated in the resistant
Hofer strain following pathogen exposure. All 13 anno-
tated genes have been previously implicated in host
immune response for other infectious diseases. Viral Hem-
orrhagic Septicemia Virus (VHSV) induced protein and neigh-
bor of COX-4 are the only annotated genes without known
molecular functions.
A common link between the majority of annotated genes
with known molecular functions is an involvement in the
interferon system. The interferon system is one of the first
lines of host defense against invading pathogens for verte-
brates (for review see [26]), including teleost fish (for
review see [27]). Other economically important salmonid
pathogens, such as infectious pancreatic necrosis virus
and infectious salmon anaemia virus have been found to
activate both type I and type II interferon (IFN) responses
in the Atlantic salmon host following infection [28]. Inter-
ferons are cytokine proteins that are secreted following
infection and play a critical role in both innate and adap-
tive immunity. The IFN system has been most widely
researched in mammals and studies have found that type
I IFN (mammalian IFN-α/β) are secreted by the pathogen-
infected cells as part of a rapid initial immune response
while Type II IFN (mammalian IFN-γ) is secreted by natu-
ral killer (NK) and T cells and plays a more central role in
the second wave of immune response. To cope with the
Experimental approach for gene expression analysis Figure 1
Experimental approach for gene expression analysis. 
Within strain comparisons were first conducted to identify 
genes responding to pathogen exposure. The expression 
profiles of these genes were then compared between resist-
ant and susceptible strains to determine which genes are 
implicated in the whirling disease phenotype.
Compare
Differentially expressed genes between strains 
Susceptible Trout Lodge Resistant Hofer
Differentially expressed 
genes within strain 
What genes are 
associated with 
resistance? 
What genes are 
associated with 
infection response? 
Differentially expressed 
genes within strain 
Unexposed
n = 4 Compare
Exposed
n = 4
Unexposed
n = 4 Compare
Exposed
n = 4BMC Genomics 2008, 9:37 http://www.biomedcentral.com/1471-2164/9/37
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myriad of host infections, the interferon system is highly
complex and involves the regulation of hundreds of genes
[29,30]. Specifically, type I IFN acts to increase MHC class
I expression for antigen presentation [31], promote T cell
survival [32], inhibit cell proliferation [33], mediate
apoptosis [26], and increase NK cell activity [34]. Type II
IFN acts to increase both MHC class I and II expression for
antigen presentation [29], stimulate macrophages to kill
engulfed pathogens [35], induce apoptosis [36], and reg-
ulate leukocyte-endothelium interactions [37] in addition
to many other immune-related activities.
It is informative to examine the functional roles of each
gene's encoded protein specifically to better understand
the part each plays, both individually and as intercon-
nected components, in host immune response. Expres-
sion of the interferon-induced 35 kDa protein is induced
by IFN and it is involved in cytokine signalling [38]. Inter-
feron regulatory factor 1 (IRF-1) and interferon regulatory
factor 7 (IRF-7) are transcription factors that induce
expression of IFN responsive genes [39,40]. Additionally,
IRF-1 is involved in apoptosis and cell cycle regulation
related to tumor suppression [41]. Similarly, cyclin-
dependent kinase 4 inhibitor B (p15-INK4b) plays a role
in apoptosis[42], cell cycle regulation [42], and tumor
suppression [43] and can be induced by the cytokine TGF-
β [44]. Gig2 is an interferon-inducible protein that is
likely part of the JAK-STAT signal transduction pathway
[45]. Ubiquitin and the proteasome subunit beta type 8
precursor are both members of the ubiquitin-proteasome
system (for review see [26]), which serves to degrade pro-
teins via proteolysis. These degraded proteins can origi-
nate from an invading pathogen and are displayed on
MHC class I proteins. The beta-2-microglobulin is an inte-
gral component of MHC class I proteins and is therefore
involved in antigen processing and presentation to cyto-
toxic T cells [46]. Haptoglobin binds hemoglobin and
limits its availability to infectious bacteria, thus prevent-
ing bacterial proliferation in a wound [47]. The PPAR-α-
interacting complex protein 285 is a transcriptional co-
activator with helicase activity [48] and has sequence sim-
ilarity to a rainbow trout VHSV-induced protein. Gene
expression of metallothionein B (MT-B) is induced by sev-
eral metal ions [49], cytokines [50-52], and stress hor-
mones [53-55]. MT proteins are believed to play diverse
functional roles in inflammation, immune response,
apoptosis, tumor suppression, and detoxification (for
reviews see [55,56]).
Microarray analysis of genes differentially expressed in the 
susceptible Trout Lodge strain in response to pathogen 
exposure
A total of six genes or features (five annotated genes, one
unknown feature) were up-regulated in the susceptible
Trout Lodge strain following pathogen exposure. Only
one of the significant genes for Trout Lodge, which has
sequence similarity to CC chemokine SCYA113, was not
also differentially expressed in Hofer in response to path-
ogen exposure. The CC chemokine SCYA113 gene is a
member of the CC chemokine family, which guides leu-
kocytes to sites of infection and inflammation (for review
see [57]). The fewer number of significant genes found for
Trout Lodge relative to Hofer may indicate a decrease in
transcriptional activation for this susceptible strain. There
is, however, likely some degree of overlap in both strains'
response to pathogen exposure due to the fact that several
genes were up-regulated in both Hofer and Trout Lodge
(i.e., ubiquitin-like protein 1, IRF-1, and PPAR-α-interacting
protein Gig2). A critical phase in the early stages of M. cer-
ebralis infection in trout is invasion and intracellular rep-
lication, processes that begin as early as one hour post
exposure to triactinomyxons [16]. A role for accumulated
ubiquinated proteins in the lysosome in the killing of
Mycobacterium tuberculosis has recently been described that
has implications for a range of intracellular infections [58]
and some similar responses to infection may be occurring
for both resistant and susceptible strains.
Microarray analysis of genes differentially expressed 
between resistant and susceptible strains in response to 
pathogen exposure
Of the genes differentially expressed in response to path-
ogen exposure for both strains, only metallothionein B
shows a statistically significant difference in expression
between the two strains (Table 2). MT-B was found to be
up-regulated in the resistant Hofer strain following path-
ogen exposure but remained unchanged in the susceptible
Trout Lodge strain.
Table 2: EST clones differentially expressed between resistant and susceptible rainbow trout strains in response to Myxobolus 
cerebralis exposure.
Gene Accession Fold Change p-value
Metallothionein B CB507722 5.20 0.002
Metallothionein B CA046225 4.06 0.004
Metallothionein B CB508872 3.52 0.007
Metallothionein B CB510653 3.84 0.004
Fold changes are computed from log ratio values (Hofer/Trout Lodge) and represent the relative increase in expression levels for Hofer versus 
Trout Lodge following pathogen exposure.BMC Genomics 2008, 9:37 http://www.biomedcentral.com/1471-2164/9/37
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As previously noted, metallothionein has been implicated
in a broad range of functional capacities, including
inflammatory and immune responses. Several cytokines
can induce metallothionein expression including IFN [59-
61], interleukin-1 [50], interleukin-6 [51], and tumor
necrosis factor-α [52]. Metallothionein has been shown to
mediate leukocyte chemotaxis and has been hypothesized
to serve as an early "danger signal" during times of stress
or infection to activate an immune response [62]. The
functional similarities between metallothionein and CC
chemokine SCYA113, at least in terms of leukocyte chem-
otaxis, are certainly of interest since these genes displayed
quite distinct expression profiles. Metallothionein was up-
regulated in the resistant Hofer strain and CC chemokine
SCYA113 was up-regulated in the susceptible Trout Lodge
strain (although CC chemokine SCYA113 did not pass the
significance cut-off to be considered differentially
expressed between the two strains). This distinction
between two genes, capable of similar biological roles,
may indicate that leukocyte movements to, and their
activities once at, the infection site are key factors in deter-
mining resistance versus susceptibility to whirling disease.
Evaluations by light microscopy and qPCR for M. cerebra-
lis genomic DNA of Hofer and Trout Lodge rainbow trout
exposed to triactinomyxons demonstrates Hofer more
efficiently eliminates invading parasites in the skin (M.
Adkison, pers. comm.). While the parasite effectively pen-
etrates the epidermis in both strains, significantly fewer
parasites survive the migration from the skin to the nerves
as evaluated at 10 d post exposure. A role for host immune
factors in the elimination of invading parasites, even in
susceptible rainbow trout strains, is suggested by several
prior light and electron microscopy studies that demon-
strate an increase in degenerative stages in the skin begin-
ning as early as 12 h and then their elimination by 24 h
post-exposure to triactinomyxons [12,16,63].
The difference in metallothionein expression may be due
to an alternative immune response pathway since the pro-
tein has known involvement in diverse functional capaci-
ties. For instance, metallothionein's role as a zinc-finger
transcriptional regulator [64] may dramatically alter the
expression profiles between resistant and susceptible rain-
bow trout. All biological roles of this diverse protein
should be considered when examining the complexities of
host immune response. Additionally, upstream regulators
of metallothionein expression could be the true underly-
ing cause of the whirling disease phenotype since a gene
expression study alone cannot determine if a gene is
directly contributing to a phenotype (i.e., cause versus
downstream effect).
Validation of microarray results by qRT-PCR
Quantitative RT-PCR (qRT-PCR) confirmed the microar-
rays results for two of the genes up-regulated in both
Hofer and Trout Lodge following infection, ubiquitin and
IRF-1, and the metallothionein gene (MT-B), which was up-
regulated in Hofer but remained unchanged in Trout
Quantitative RT-PCR expression results for genes respond- ing to Myxobolus cerebralis infection in the skin tissue of both  strains Figure 2
Quantitative RT-PCR expression results for genes 
responding to Myxobolus cerebralis infection in the 
skin tissue of both strains. A) Ubiquitin-like protein 1 is 100 
– 134 fold up-regulated following pathogen exposure for 
both strains. B) Interferon regulating factor 1 (IRF-1) is up-regu-
lated 16 – 18 fold up-regulated for both strains. C) Metal-
lothionein B (MT-B) is up-regulated over 5 fold in the resistant 
Hofer but is unchanged in the susceptible Trout Lodge strain. 
Asterisks represent significance (** = P < 0.005; *** = P < 
0.001). Abbreviations: HC = Hofer Control; HE = Hofer 
Exposed; TLC = Trout Lodge Control; TLE = Trout Lodge 
Exposed.
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Lodge following infection (Figure 2). The qRT-PCR results
for IRF-1  and  metallothionein  were quite similar to the
microarray results for each gene, in terms of relative
expression changes in response to infection. MT-B was
found to once again be significantly up-regulated in the
resistant Hofer strain following pathogen exposure but
remained unchanged in the susceptible Trout Lodge. This
difference in MT-B  gene expression between the two
strains was statistically significant (P ~ 0.001). The relative
degree of up-regulation for ubiquitin following pathogen
exposure was considerably higher in the qRT-PCR (~9 –
17 fold greater up-regulation in qRT-PCR versus microar-
rays). Many other studies have also observed this pattern
of greater sensitivity in qRT-PCR versus microarray results
(for examples see [65,66], which is often attributed to the
more gene-specific optimized conditions of the qRT-PCR
approach.
Given the high degree of statistical support and biological
relevance of the candidate genes, we believe this study
provides initial insight into rainbow trout genes and path-
ways responding to whirling disease infection and identi-
fies the first candidate genes for whirling disease
resistance.
Potential future studies
While the interferon system appears to be a likely candi-
date system for further study, many of the significant
genes are found in alternative pathways and have distinct
roles and functions in other systems. Furthermore, it is
increasingly apparent that epistatic interactions and the
interplay between pathways/networks previously classi-
fied as discrete can have enormous phenotypic effects on
quantitative traits [67]. Multiple avenues of research
should be examined in future studies, using the candidate
genes presented here as an initial guide, due to the com-
plex relationships between hosts and pathogens. For
instance, the migration of leukocytes and their subse-
quent activity in the skin are likely a critical part of the
early immune and inflammatory host response after path-
ogen infection. Additionally, it is quite feasible that the
difference in metallothionein expression is due to an
alternative immune response pathway since the protein
has known involvement in diverse functional capacities.
For instance, metallothionein's role as a zinc-finger tran-
scriptional regulator [64] may dramatically alter the
expression profiles between resistant and susceptible rain-
bow trout. All biological roles of this diverse protein
should be considered when examining the complexities of
host immune response. Finally, upstream regulators of
metallothionein expression could be the true underlying
cause of the whirling disease phenotype since a gene
expression study alone cannot determine if a gene is
directly contributing to a phenotype (i.e., cause versus
downstream effect). The expression profiles of a variety of
metallothionein upstream regulators, such as cytokines
and metal transcription factor (MTF-1), could be evaluated
in a time course study during early disease progression to
identify additional candidate genes. A QTL mapping
approach could also be used to identify particular chro-
mosomal regions directly contributing to the disease phe-
notype.
Conclusion
The present study has provided the first examination into
the genetic basis underlying rainbow trout's immune
response and resistance to the whirling disease pathogen.
Several genes were significantly up-regulated in skin fol-
lowing pathogen exposure for both the resistant Hofer
and susceptible Trout Lodge rainbow trout strains. For
both strains, response to infection appears to be linked
with the interferon system. Metallothionein B is differen-
tially expressed between the resistant and susceptible
strains and is a good candidate for future whirling disease
resistance studies. The identified genes have allowed us to
gain initial insight into the molecular mechanisms
involved in a salmonid host's immune response and
resistance to whirling disease infection.
Methods
Animal care, pathogen exposure, and RNA preparation
Hofer and Trout Lodge rainbow trout strains were reared
in 35 gallon aquaria with 15°C flow-through well water
for nine weeks post-hatch, with each fish weighing
approximately 6.5 grams prior to pathogen exposure.
Individuals from each strain (n = 60) were exposed to
2,000 triactinomyxons (TAMs) per fish for one hour.
Additional fish (n = 60) from both strains served as unex-
posed controls, which were treated identically to exposed
fish at all experimental stages other than their lack of
pathogen exposure. Fish were then kept under standard
aquaculture conditions until euthanized. TaqMan PCR for
the quantitative evaluation of genomic parasite DNA was
employed to confirm that fish in both the Hofer and Trout
Lodge groups received equal amounts of parasite expo-
sure. At two hours post TAM exposure, 6 fish in each
exposed group were removed and euthanized with an
overdose of benzocaine at a concentration of 500 mg/L.
Caudal fins were removed posterior to the peduncle and
used as the tissue for a quantiative TaqMan assay follow-
ing procedures described by Kelley et al. [68].
Microarray studies examining skin four hours after patho-
gen exposure did not identify any genes differentially
expressed between Trout Lodge and Hofer strains (data
not shown). Therefore, we chose a later time point (24
hours after exposure) so that early host immune response
was more likely to be fully underway and significant
expression changes could be detected. After the 24 hour
incubation period, all fish were euthanized with an over-BMC Genomics 2008, 9:37 http://www.biomedcentral.com/1471-2164/9/37
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dose of benzocaine at a concentration of 500 mg/L. Each
fish was euthanized individually and the caudal fin
(largely comprised of skin tissue) was removed posterior
to the peduncle. The fin was immediately placed into 2×
Nucleic Acid Purification Lysis Solution supplied with
ABI's TransPrep Chemistry kit (Applied Biosystems, Foster
City, CA) to stop further gene expression changes. Total
RNA was extracted from the fin of each individual using
the ABI Prism™ TransPrep system with the ABI Prism™
6100 Nucleic Acid PrepStation according to manufacturer
instructions. RNA quality was assessed by agarose gel elec-
trophoresis and RNA concentrations were measured using
a ND-1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE).
Starting total RNA yields were not sufficient for microar-
ray hybridizations due to the small amount of caudal fin
tissue present on these young fish. Therefore, 250 – 1000
ng of total RNA was used as the starting material to create
amplified RNA (aRNA) indirectly labeled with Cy3 or Cy5
fluorescent dyes (GE Healthcare, Buckinghamshire, UK)
using the Amino Allyl MessageAmp™ II aRNA Amplifica-
tion kit according to manufacturer instructions (Ambion,
Austin, TX).
Microarray hybridization and data analysis
Salmonid cDNA microarrays (GRASP16k v2.0) were
obtained from consortium for Genomic Research on
Atlantic Salmon (cGRASP) and details of microarray
development and fabrication can be found in von Schal-
burg et al. [69]. These arrays contain 13,421 Atlantic
salmon and 2,576 rainbow trout cDNA features and have
been successfully used for several previous rainbow trout
gene expression studies [70-73]. For each rainbow trout
strain, competitive hybridization was conducted on every
array using equal amounts (8 µg) of differentially labeled
aRNA from one control fish and one exposed fish. Four
biological replicates were performed for each experimen-
tal condition and dye-sample coupling was swapped
between biological replicates in a balanced block design.
Prehybridization washes for all microarrays included: 2 ×
5 min in 0.1% SDS, 5 × 1 min in NANOpure H2O with 0.5
mM dithiothreotol, 1 min in near boiling nanopure H2O,
centrifugation for 2 min at 1500 RPM. To reduce back-
ground, the microarrays were next incubated for 90 min
in 5 × SSC, 0.1% SDS, 3% BSA (Fraction V) at 49°C,
washed 3 × 20 s in nanopure H2O, and dried by centrifu-
gation for 5 min at 1500 RPM. The labeled aRNA samples
were competitively hybridized to microarrays prewarmed
to 49°C for 16 hours in a formamide-based buffer (Geni-
sphere, Hatfield, PA) with LNA dT blocker (Genisphere).
Posthybridization washes for all microarrays included: 1 ×
10 min in 2 × SSC, 0.1% SDS prewarmed to 49°C, 2 × 5
min in 2 × SSC, 0.1% SDS at room temperature, 2 × 5 min
1 × SSC at room temperature, 2 × 5 min 0.1 × SSC at room
temperature. Slides were then dried by centrifugation and
immediately scanned using an Agilent G2565BA Microar-
ray Scanner (Agilent Technologies, Santa Clara, CA).
Data underwent local background subtraction and LOW-
ESS normalization using Agilent's Feature Extraction soft-
ware. Raw and processed gene expression data have been
deposited into the NCBI Gene Expression Omnibus [74]
(series GSE8631) and are in compliance with MIAME
guidelines. The Significance Analysis of Microarrays
(SAM) software package [75] was used to identify differ-
entially expressed genes between exposed and unexposed
control fish for each rainbow trout strain. Both a Wil-
coxon rank sum and a modified t-test were conducted
with 1,000 permutations and the minimum fold change
cut-off was set to 2.0 up- or down-regulated. A false dis-
covery rate (FDR) of 0.00% was estimated for both strains.
To determine statistically significant differences between
the Hofer and Trout Lodge strains, a Welch's t-test (P-
value < 0.01) was implemented in Microsoft Excel
between the log ratios (exposed/control) for each strain
for all genes that were significant for at least one strain in
the SAM program.
Quantitative RT-PCR
Microarray expression results were validated by qRT-PCR
for several identified genes. Prior to qRT-PCR, 80 ng of
total RNA was reverse transcribed from each biological
replicate used for the microarray study along with two
additional samples (total n = 6 per experimental condi-
tion) using the QuantiScript Reverse Transcriptase kit
(Qiagen, Valencia, CA) according to manufacturer
instructions. In contrast to the microarray experiments,
the template RNA was not amplified before cDNA synthe-
sis. EST clone sequences from the cGRASP microarray
were used to design primers for genes undergoing valida-
tion, along with a β-actin reference gene used for normal-
ization, with Primer3 software [76] and the sequence for
each primer pair is shown in Table 3. The Quantitect™
SYBR® Green RT-PCR kit (Qiagen) was used according to
the manufacturer's instructions except the final PCR vol-
ume was reduced to 25 µl. The PCR conditions used on a
Chromo4 Real Time PCR Detection System (Bio-Rad,
Hercules, CA) were as follows: HotStarTaq DNA polymer-
ase activation at 95°C for 15 min, 45 cycles of 15 s dena-
turation at 94°C, 30 s annealing at 58°C, 30 s extension
at 72°C, followed by a melting curve to ensure that a sin-
gle PCR product was produced for each reaction. For each
gene, the relative amount of gene expression was calcu-
lated using the ∆∆CT method [77] and significance was
determined using a nonparametric Mann-Whitney U test
and multiple linear regression in JMP.BMC Genomics 2008, 9:37 http://www.biomedcentral.com/1471-2164/9/37
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